HRT Financial LP

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
2,457
Total Value
15800109
Accession Number
0001475597-25-000019
Form Type
13F-HR
Manager Name
HRT Financial LP
Data Enrichment
71% identified
1,747 identified710 unidentified

Holdings

2,457 positions
Manager:
Search and click to pin securities to the top
Page 105 of 123
ARVINAS, INC.
Shares:
22797
Value:
$160.0K
Cullinan Therapeutics, Inc.
Shares:
20850
Value:
$157.0K
Theravance Biopharma, Inc.
Shares:
17490
Value:
$156.0K
Nano Dimension Ltd.
Shares:
98426
Value:
$156.0K
CREDIT SUISSE ASSET MANAGEMENT INCOME FUND, INC.
Shares:
53644(+51.8%)
Value:
$155.0K(+52.0%)
MERCER INTERNATIONAL INC.
Shares:
25074
Value:
$154.0K
Vivid Seats Inc.
Shares:
51682(+12.6%)
Value:
$152.0K(-28.3%)
BLACKROCK MUNIYIELD QUALITY FUND, INC.
Shares:
13039
Value:
$152.0K
Designer Brands Inc.
Shares:
41470(+93.5%)
Value:
$151.0K(+32.5%)
Evolus, Inc.
Shares:
12564(-46.6%)
Value:
$151.0K(-41.7%)
Mister Car Wash, Inc.
Shares:
19137(-56.2%)
Value:
$150.0K(-52.8%)
Keros Therapeutics, Inc.
Shares:
14747
Value:
$150.0K
Annexon, Inc.
Shares:
78100
Value:
$150.0K
Eaton Vance Ltd Duration Income Fund
Shares:
14966(-25.5%)
Value:
$149.0K(-24.0%)
Blackstone Long-Short Credit Income Fund
Shares:
12133
Value:
$149.0K
BRAZILIAN ELECTRIC POWER CO
Shares:
20850(+38.1%)
Value:
$148.0K(+72.1%)
Crexendo, Inc.
Shares:
30480
Value:
$148.0K
2seventy bio, Inc.
Shares:
29515
Value:
$145.0K
Fulcrum Therapeutics, Inc.
Shares:
50490(-25.8%)
Value:
$145.0K(-54.5%)
Inhibikase Therapeutics, Inc.
Shares:
65906(+42.0%)
Value:
$144.0K(-4.0%)